Upgrade to SI Premium - Free Trial

Arcus Biosciences (RCUS) Reiterated at Overweight by Cantor Fitzgerald After CFO Chat

September 11, 2026 7:03 AM
Cantor Fitzgerald analyst Li Watsek reiterated an Overweight rating on Arcus Biosciences (NYSE: RCUS).The analyst commented, "We hosted Arcus CFO ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments